摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1'-bis(diphenylphosphino)ethane | 28240-60-0

中文名称
——
中文别名
——
英文名称
1,1'-bis(diphenylphosphino)ethane
英文别名
2-bis(diphenylphosphino)ethane;(Ethane-1,1-diyl)bis(diphenylphosphane);1-diphenylphosphanylethyl(diphenyl)phosphane
1,1'-bis(diphenylphosphino)ethane化学式
CAS
28240-60-0
化学式
C26H24P2
mdl
——
分子量
398.424
InChiKey
UAXNXOMKCGKNCI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    504.5±33.0 °C(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

SDS

SDS:9e05cfbae094cb97deaa7da5f64dc61d
查看

反应信息

  • 作为反应物:
    描述:
    1,1'-bis(diphenylphosphino)ethane四氢呋喃二氯甲烷 为溶剂, 生成 [Mo(CO)4(Ph2PCMe2PPh2)]
    参考文献:
    名称:
    Backbone modified small bite-angle diphosphines: Synthesis and molecular structures of [M(CO)4{X2PC(R1R2)PX2}] (M=Mo, W; X=Ph, Cy; R1=H, Me, Et, Pr, allyl, R2=Me, allyl)
    摘要:
    A range of new small bite-angle diphosphine complexes, [M(CO)(4) {X2PC((RR2)-R-1)PX2}] (M = Mo, W; X = Ph, Cy; R-1 = H, Me, Et, Pr, allyl, R 2 = Me, allyl), have been prepared via elaboration of the methylene backbones in [M(CO)(4)(X2PCH2PX2)] as a result of successive deprotonation and alkyl halide addition. When X = Ph it proved possible to replace both methylene protons but for X = Cy only one substitution proved possible. This is likely due to the electron-releasing nature of the cyclohexyl groups but may also be due to steric constraints. Attempts to prepare the bis(allyl) substituted complex [Mo(CO)(4){Ph2PC(allyl)(2)PPh2}] were only moderately successful. The crystal structures of nine of these complexes are presented. (C) 2007 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.jorganchem.2007.09.024
  • 作为产物:
    描述:
    二氯甲烷 为溶剂, 反应 4.0h, 以20%的产率得到1,1'-bis(diphenylphosphino)ethane
    参考文献:
    名称:
    P ?的直接,模块化和有效的构造。C ?锰卡宾配合物与膦偶联的P结构基序
    摘要:
    在分别与仲或叔膦偶联后,在温和条件下进行脱金属后,容易获得的锰的碳炔络合物被用作非常规合成的骨架取代的二膦甲烷和环状P-化烯的碳炔片段的来源。
    DOI:
    10.1002/chem.201304239
  • 作为试剂:
    描述:
    2-溴丙烯Phenylsulfonyl-2 hexadiene-4,5 oate de methyle1,1'-bis(diphenylphosphino)ethane 、 bis(dibenzylideneacetone)-palladium(0) sodium hydride 作用下, 生成 Carbomethoxy-4 isopropenyl-1 phenylsulfonyl-4 cyclopentene
    参考文献:
    名称:
    Formation de derives cyclopenteniques et vinylcyclopropaniques lors de la carbopalladation de diesters et d' α-sulfonylesters alleniques
    摘要:
    DOI:
    10.1016/s0040-4020(01)81636-7
点击查看最新优质反应信息

文献信息

  • [EN] VIRAL POLYMERASE INHIBITORS<br/>[FR] INHIBITEURS DE POLYMERASE VIRALE
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2004065367A1
    公开(公告)日:2004-08-05
    An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula (I): wherein wherein A, B, R2, R3, L, M1, M2, M3, M4, Y1, Y0, Z and Sp are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase.
    化合物的异构体、对映体、非对映异构体或互变异构体,由式(I)所代表:其中A、B、R2、R3、L、M1、M2、M3、M4、Y1、Y0、Z和Sp如权利要求1中定义,或其盐,作为HCV NS5B聚合酶的抑制剂。
  • [EN] HERBICIDALLY ACTIVE HETEROARYL-S?BSTIT?TED CYCLIC DIONES OR DERIVATIVES THEREOF<br/>[FR] DIONES CYCLIQUES SUBSTITUÉES PAR HÉTÉROARYLE À ACTIVITÉ HERBICIDE OU DÉRIVÉS DE CELLES-CI
    申请人:SYNGENTA LTD
    公开号:WO2011012862A1
    公开(公告)日:2011-02-03
    The invention relates to a compound of formula (I), which is suitable for use as a herbicide wherein G is hydrogen or an agriculturally acceptable metal, sulfonium, ammonium or latentiating group; Q is a unsubstituted or substituted C3-C8 saturated or mono-unsaturated heterocyclyl containing at least one heteroatom selected from O, N and S, or Q is heteroaryl or substituted heteroaryl; m is 1, 2 or 3; and Het is an optionally substituted monocyclic or bicyclic heteroaromatic ring; and wherein the compound is optionally an agronomically acceptable salt thereof.
    该发明涉及一种化合物,其化学式为(I),适用作为除草剂,其中G为氢或农业可接受的金属、磺酸盐、铵盐或潜伏基团;Q为未取代或取代的含有至少一个来自O、N和S的杂原子的饱和或单不饱和的C3-C8杂环烷基,或Q为杂芳基或取代的杂芳基;m为1、2或3;Het为可选择地取代的单环或双环杂芳环;且该化合物可选择地为其农学上可接受的盐。
  • [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
    申请人:HOFFMANN LA ROCHE
    公开号:WO2014135471A1
    公开(公告)日:2014-09-12
    The present invention discloses compounds of Formula (I): wherein the variables in Formula (I) are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula (I) in the prevention or treatment of HCV infection.
    本发明公开了化合物的结构式(I):其中式(I)中的变量如本文所述。还公开了含有这种化合物的药物组合物,以及使用式(I)中的化合物预防或治疗HCV感染的方法。
  • [EN] SUBSTITUTED 2-AZABICYCLO[3.1.1]HEPTANE AND 2-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE 2-AZABICYCLO[3.1.1]HEPTANE ET DE 2-AZABICYCLO[3.2.1]OCTANE SUBSTITUÉS EN TANT QU'ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE
    申请人:CHRONOS THERAPEUTICS LTD
    公开号:WO2019043407A1
    公开(公告)日:2019-03-07
    There is provided a compound of formula (I), wherein L1 to L3, R1 to R4, X, A and B have meanings given in the description, and pharmaceutically acceptable salts, solvates and prodrugs thereof, which compounds are useful as antagonists of the orexin-1 and orexin-2 receptors or as selective antagonists of the orexin-1 receptor, and thus, in particular, in the treatment or prevention of inter alia substance dependence, addiction, anxiety disorders, panic disorders, binge eating, compulsive disorders, impulse control disorders, cognitive impairment and Alzheimer's disease.
    提供一种化合物,其化学式为(I),其中L1至L3,R1至R4,X,A和B的含义如描述中所给,并且其药学上可接受的盐、溶剂合物和前药,这些化合物可用作促进睡眠素-1和促进睡眠素-2受体的拮抗剂或作为促进睡眠素-1受体的选择性拮抗剂,因此,特别适用于治疗或预防物质依赖、成瘾、焦虑障碍、恐慌障碍、暴饮暴食、强迫障碍、冲动控制障碍、认知障碍和阿尔茨海默病等疾病。
  • [EN] PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST<br/>[FR] PROCÉDÉ DE PRÉPARATION D'UN ANTAGONISTE DU RÉCEPTEUR DE L'OREXINE
    申请人:MERCK SHARP & DOHME
    公开号:WO2012058129A1
    公开(公告)日:2012-05-03
    The present invention is directed to processes for preparing a pyridyl piperidine compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved.
    本发明涉及制备吡啶基哌啶化合物的方法,该化合物是促进睡眠的受体拮抗剂,可用于治疗或预防涉及促进睡眠的神经和精神障碍和疾病。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐